发明授权
- 专利标题： Inhibitors of hepatitis C virus
- 专利标题（中）： 丙型肝炎病毒的抑制剂
-
申请号： US13288216申请日： 2011-11-03
-
公开(公告)号： US08921372B2公开(公告)日： 2014-12-30
- 发明人: Robert Murray McKinnell , Daniel D. Long , Lori Jean Van Orden , Lan Jiang , Mandy Loo , Daisuke Roland Saito , Sheila Zipfel , Eric L. Stangeland , Kassandra Lepack , Gavin Ogawa , Xiaojun Huang , Weijiang Zhang
- 申请人： Robert Murray McKinnell , Daniel D. Long , Lori Jean Van Orden , Lan Jiang , Mandy Loo , Daisuke Roland Saito , Sheila Zipfel , Eric L. Stangeland , Kassandra Lepack , Gavin Ogawa , Xiaojun Huang , Weijiang Zhang
- 申请人地址： US CA South San Francisco
- 专利权人： Theravance Biopharma R&D IP, LLC
- 当前专利权人： Theravance Biopharma R&D IP, LLC
- 当前专利权人地址： US CA South San Francisco
- 代理商 Jeffrey A. Hagenah; Roberta P. Saxon
- 主分类号： A61K31/497
- IPC分类号： A61K31/497 ; C07D401/14 ; C07D403/14 ; A61P1/16
摘要：
The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.
公开/授权文献
- US20120114600A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS 公开/授权日：2012-05-10
信息查询
IPC分类:
